Atreca Inc. (BCEL) PT Lowered to $17 at Brookline Capital Markets, Following Clinical Business Update

Go back to Atreca Inc. (BCEL) PT Lowered to $17 at Brookline Capital Markets, Following Clinical Business Update
(NASDAQ: BCEL) Delayed: 5.20 +0.05 (0.97%)
Previous Close $5.15    52 Week High
Open $5.16    52 Week Low
Day High $5.27    P/E N/A 
Day Low $5.16    EPS
Volume 15,335